NCT00917579
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Miami, Florida, United States
Clinical trial condition
Hypercholesterolemia
Explore clinical trials studying Hypercholesterolemia. Study availability and eligibility vary by location and protocol.
719 public trials
20 recruiting studies
Hypercholesterolemia trial results
NCT00844376
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
NCT00794677
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Cholesterol Research Center Berkeley, California, United States
NCT03067441
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
- Locations
-
- Jedidiah Clinical Research Tampa, Florida, United States
- L-MARC Research Center Louisville, Kentucky, United States
- Sentral Clinical Research Services Cincinnati, Ohio, United States
NCT01964326
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Robert's Discount Pharmacy Hoover, Alabama, United States
- Pharmacy at the Pig McCalla, Alabama, United States
- Pinson Discount Drugs Pinson, Alabama, United States
- Community Clinical Pharmacy Mesa, Arizona, United States
NCT00917644
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Miami, Florida, United States
NCT00150371
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Edmonton, Alberta, Canada
NCT00163202
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Edmonton, Alberta, Canada
- Pfizer Investigational Site Vancouver, British Columbia, Canada
- Pfizer Investigational Site Winnipeg, Manitoba, Canada
NCT00141141
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site S. Benedetto DEL Tronto, Ascoli Piceno, Italy
- Pfizer Investigational Site S.Pietro Vernotico, Brindisi, Italy
- Pfizer Investigational Site Casarano, Lecce, Italy
- Pfizer Investigational Site Pavia, PV, Italy
Completed
Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke
NCT00163150
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Pfizer Investigational Site Paris, France